Ethical Innovation for Global Health
Springer Verlag, Singapore
978-981-99-6162-7 (ISBN)
- Titel nicht im Sortiment
- Artikel merken
Ethical Innovation for Global Health: Pandemic, Democracy and Ethics in Research is an informative resource for academic researchers, the global pharmaceutical industry, regulators, civil society and other role players involved in global health. It is contributed to by leaders in global policy development in research ethics, and experts in drug development activities with its trajectory being global health. The COVID-19 pandemic, as a global disaster, necessitated not only socio-economic but also cultural transformation. While effective vaccines were developed under a successful new methodology, there remains inequity of distribution of these vaccines globally. The book re-engages with the notion of the primacy of distributing results of scientific innovation to those who most require the benefits.
Chieko KuriharaNational Institutes for Quantum and Radiological Science and Technology Inage-ku ChibaJapan Dirceu Greco Federal University of Minas Gerais Belo Horizonte Brazil Ames DhaiUniversity of the Witwatersrand School of Clinical Medicine Johannesburg South Africa
1 Introduction to Ethical innovation for global health: pandemic, democracy and ethics in research. Part 1 Relevant constructions from a middle-income country (MIC) and/or non-Western paradigms: Brazil, South Africa, Taiwan, South Korea, and Japan.- 2 Democracy restoration in Brazil, the constitutional guarantee of health as a right for all, giving rise to a universal health system (SUS) and of a National Research Ethics Commission.- 3 Equitable access to COVID-19 vaccines, vaccine research and Vaccine Apartheid on the African continent: challenges and recommendations.- 4 Response to Covid-19 pandemic and Ethical Innovations in Taiwan.- 5 Between truth and profit: Scientific misconduct case of human cloned embryonic stem cell and revisiting cases during COVID-19 pandemic.- 6 Therapeutic misconception as the basis for vaccine nationalism of Japan: a historical reflection and perspectives for global public health.- Part 2 Historical and international perspectives on the development of ethical principles in research involving humans.- 7 The Declaration of Helsinki as a living document: Revisiting its principles in a global pandemic.- 8 Hidden Medical War Crimes and the Emergence of Bioethics in Japan.- 9 From Nuremberg to Helsinki: Historicizing the Codification of Post-War Research Ethics.- 10 CIOMS research guidelines: Considering the needs of developing countries.- 11 Ethics of placebo-controlled trial: historical analysis including the experience of COVID-19 pandemic.- 12 Post-trial access: historical analysis considering the experience of COVID-19 pandemic.- 13 Our “WMA Declaration of Helsinki”: opinions and pro-posals from patient and public for research ethics.- Part 3 Alternative frameworks for innovation and drug development strategies.- 14 Medicines development for global health: Learning from COVID-19 vaccines R&D.- 15 Development of portfolios and pipelines of drugs for the treatment, prevention and control of neglected tropicaldiseases.- 16 Patient and Public Involvement (PPI) and pharmaceutical development through Open Innovation Processes ~ recent activities.
Erscheinungsdatum | 09.12.2023 |
---|---|
Zusatzinfo | 49 Illustrations, color; XXIX, 312 p. 49 illus. in color. |
Verlagsort | Singapore |
Sprache | englisch |
Maße | 155 x 235 mm |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Medizinethik |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
Medizin / Pharmazie ► Pflege | |
Studium ► Querschnittsbereiche ► Geschichte / Ethik der Medizin | |
Naturwissenschaften ► Biologie | |
Schlagworte | Bioethics • Covid-19 • drug development • Neglected Disease • research ethics • research participants |
ISBN-10 | 981-99-6162-9 / 9819961629 |
ISBN-13 | 978-981-99-6162-7 / 9789819961627 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich